Tumor-induced Bregs (tBregs) can initiate the regulatory subset functions of MDSCs and suppress antitumor immunity, which is partially dependent on TGFβR1/TGFβR2 signaling 86. The gene discussed is TGFBR2; the disease is neoplasm.